|
| 36306822 | Children with malignancies and septic shock - an attempt to understand the risk factors. | J Pediatr (Rio J) | 2023 |
| 36306822 | Children with malignancies and septic shock - an attempt to understand the risk factors. | J Pediatr (Rio J) | 2023 |
| 36922454 | Quantitative expression evaluation of PRAME gene in osteosarcoma. | Mol Biol Rep | 2023 |
| 36982681 | Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. | Int J Mol Sci | 2023 |
| 36982681 | Pharmacogenetics of the Primary and Metastatic Osteosarcoma: Gene Expression Profile Associated with Outcome. | Int J Mol Sci | 2023 |
| 36922454 | Quantitative expression evaluation of PRAME gene in osteosarcoma. | Mol Biol Rep | 2023 |
| 33440404 | ALVEOLAR RECRUITMENT MANEUVERS FOR CHILDREN WITH CANCER AND ACUTE RESPIRATORY DISTRESS SYNDROME: A FEASIBILITY STUDY. | Rev Paul Pediatr | 2021 |
| 33440404 | ALVEOLAR RECRUITMENT MANEUVERS FOR CHILDREN WITH CANCER AND ACUTE RESPIRATORY DISTRESS SYNDROME: A FEASIBILITY STUDY. | Rev Paul Pediatr | 2021 |
| 34666222 | Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel. | Cancer Genet | 2021 |
| 34666222 | Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel. | Cancer Genet | 2021 |
| 32191290 | Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. | JAMA Oncol | 2020 |
| 32145682 | MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma. | Ann Diagn Pathol | 2020 |
| 32191290 | Frequency of Pathogenic Germline Variants in Cancer-Susceptibility Genes in Patients With Osteosarcoma. | JAMA Oncol | 2020 |
| 32298597 | <i>CYP</i> Genotypes Are Associated with Toxicity and Survival in Osteosarcoma Patients. | J Adolesc Young Adult Oncol | 2020 |
| 31812554 | Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. | Lancet Oncol | 2020 |
| 32986390 | PRISM 4-C: An Adapted PRISM IV Algorithm for Children With Cancer. | J Pediatr Hematol Oncol | 2020 |
| 33164827 | Invasive pneumococcal disease in children with cancer: Incidence density, risk factors and isolated serotypes. | Braz J Infect Dis | 2020 |
| 31812554 | Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial. | Lancet Oncol | 2020 |
| 33164827 | Invasive pneumococcal disease in children with cancer: Incidence density, risk factors and isolated serotypes. | Braz J Infect Dis | 2020 |
| 32986390 | PRISM 4-C: An Adapted PRISM IV Algorithm for Children With Cancer. | J Pediatr Hematol Oncol | 2020 |
| 32145682 | MAPK7 variants related to prognosis and chemotherapy response in osteosarcoma. | Ann Diagn Pathol | 2020 |
| 32298597 | <i>CYP</i> Genotypes Are Associated with Toxicity and Survival in Osteosarcoma Patients. | J Adolesc Young Adult Oncol | 2020 |
| 30687957 | A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer. | Mycoses | 2019 |
| 30687957 | A pharmacokinetic model for voriconazole in a highly diversified population of children and adolescents with cancer. | Mycoses | 2019 |
| 31292491 | New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X. | Sci Rep | 2019 |
| 31292491 | New therapeutic target for pediatric anaplastic ependymoma control: study of anti-tumor activity by a Kunitz-type molecule, Amblyomin-X. | Sci Rep | 2019 |
| 29210060 | Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. | Int J Cancer | 2018 |
| 30128431 | The influence of cell concentration at cryopreservation on neutrophil engraftment after autologous peripheral blood stem cell transplantation. | Hematol Transfus Cell Ther | 2018 |
| 30365807 | IN TIME: WHAT IS THE STATUS OF THE CARE GIVEN TO CHILDREN WITH CANCER? | Rev Paul Pediatr | 2018 |
| 29668078 | Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center. | Transpl Infect Dis | 2018 |
| 29210060 | Genome-wide association study identifies the GLDC/IL33 locus associated with survival of osteosarcoma patients. | Int J Cancer | 2018 |
| 29774098 | Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology. | Oncotarget | 2018 |
| 30128431 | The influence of cell concentration at cryopreservation on neutrophil engraftment after autologous peripheral blood stem cell transplantation. | Hematol Transfus Cell Ther | 2018 |
| 30365807 | IN TIME: WHAT IS THE STATUS OF THE CARE GIVEN TO CHILDREN WITH CANCER? | Rev Paul Pediatr | 2018 |
| 29668078 | Adherence and immune response to revaccination following hematopoietic stem cell transplantation at a pediatric onco-hematology reference center. | Transpl Infect Dis | 2018 |
| 29774098 | Establishment of primary cell culture and an intracranial xenograft model of pediatric ependymoma: a prospect for therapy development and understanding of tumor biology. | Oncotarget | 2018 |
| 28769538 | Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway. | Mediators Inflamm | 2017 |
| 28912948 | Outbreak of <i>Fusarium oxysporum</i> infections in children with cancer: an experience with 7 episodes of catheter-related fungemia. | Antimicrob Resist Infect Control | 2017 |
| 28769538 | Cytokine Kinetics in Febrile Neutropenic Children: Insights on the Usefulness as Sepsis Biomarkers, Influence of Filgrastim, and Behavior of the IL-23/IL-17 Pathway. | Mediators Inflamm | 2017 |
| 28404946 | CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response. | Oncotarget | 2017 |
| 28263383 | Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment. | Cancer | 2017 |
| 28112450 | MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets. | Mol Carcinog | 2017 |
| 28112450 | MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets. | Mol Carcinog | 2017 |
| 28404946 | CYP genes in osteosarcoma: Their role in tumorigenesis, pulmonary metastatic microenvironment and treatment response. | Oncotarget | 2017 |
| 28263383 | Results of a randomized, prospective clinical trial evaluating metronomic chemotherapy in nonmetastatic patients with high-grade, operable osteosarcomas of the extremities: A report from the Latin American Group of Osteosarcoma Treatment. | Cancer | 2017 |
| 28912948 | Outbreak of <i>Fusarium oxysporum</i> infections in children with cancer: an experience with 7 episodes of catheter-related fungemia. | Antimicrob Resist Infect Control | 2017 |
| 27585633 | Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients. | BMC Infect Dis | 2016 |
| 26558810 | Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer. | J Pediatr Hematol Oncol | 2016 |
| 26460937 | MAPK7 gene controls proliferation, migration and cell invasion in osteosarcoma. | Mol Carcinog | 2016 |
| 27585633 | Clinical relevance of molecular identification of microorganisms and detection of antimicrobial resistance genes in bloodstream infections of paediatric cancer patients. | BMC Infect Dis | 2016 |